Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Журнал акушерства и ...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Журнал акушерства и женских болезней
Article . 2011
Data sources: CyberLeninka - Russian open access scientific library
Claim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Терапия предменструального синдрома эстроген-гестагенным препаратом, содержащим 20 мкг этинил-эстрадиола и 3 мг дроспиренона

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2011 Russian Publisher:Общество с ограниченной ответственностью «Эко-Вектор»Journal:Журнал акушерства и женских болезней (issn: 1684-0461, eissn: 1683-9366, Copyright policy )

Терапия предменструального синдрома эстроген-гестагенным препаратом, содержащим 20 мкг этинил-эстрадиола и 3 мг дроспиренона

Abstract

Монофазный низкодозированный пероральный эстроген-гестагенный препарат Джес, содержащий 20 мкг этинилэстрадиола и 3 мг дроспиренона, клинически эффективен при предменструальном синдроме. При применении Джес отмечено выраженное уменьшение симптомов, связанных с задержкой жидкости, и вегетососудистых проявлений ПМС, существенное ослабление психоэмоциональной симптоматики заболевания

Keywords

ПРЕДМЕНСТРУАЛЬНЫЙ СИНДРОМ,ЭСТРОГЕН-ГЕСТАГЕННЫЕ ПРЕПАРАТЫ,МОНОФАЗНЫЕ КОМБИНИРОВАННЫЕ КОНТРАЦЕПТИВЫ,ДРОСПИРЕНОН,ДЖЕС

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
bronze